Supplementary Figure 2 from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials

Ming‐Wen An, Sumithra J. Mandrekar, Megan E. Branda, Shauna L. Hillman, Alex A. Adjei, Henry C. Pitot, Richard M. Goldberg, Daniel J. Sargent

Type: Preprint

Publication Date: 2023-03-31

Citations: 0

DOI: https://doi.org/10.1158/1078-0432.22445202.v1

Locations

INDIGO (University of Illinois at Chicago) - View - PDF

Similar Works

Action	Title	Year	Authors
+	Supplementary Figure 2 from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2023	Ming‐Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+	Supplementary Figure 1 from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2023	Ming‐Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+	Supplementary Figure 1 from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2023	Ming‐Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+ PDF Chat	Comparison of Continuous versus Categorical Tumor Measurement-Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2011	Ming An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+	Data from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2023	Ming‐Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+	Data from Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2023	Ming‐Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+ PDF Chat	Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials	2011	Ming-Wen An Sumithra J. Mandrekar Megan E. Branda Shauna L. Hillman Alex A. Adjei Henry C. Pitot Richard M. Goldberg Daniel J. Sargent
+	Application of Tumor Measurement–Based Metrics in the Real World	2013	Ming-Wen An Sumithra J. Mandrekar Daniel J. Sargent
+	Objective Response Rate and Progression-Free Survival as Surrogates for Overall Survival Treatment Effect: A Meta-analysis across Diverse Tumour Groups and Contemporary Therapies	2023	Adel Shahnam Nadia Hitchen Udit Nindra Sathya Manoharan Jayesh Desai Ben Tran Benjamin Solomon Stephen J. Luen Rina Hui Ashley M. Hopkins
+	Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors	2017	Stefan Michiels Everardo D. Saad Marc Buyse
+ PDF Chat	Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed	2023	Anushka Walia Jordan Tuia Vinay Prasad
+ PDF Chat	How to Make a Better-Informed Go-No-Go Decision in Oncology Trials Using Tumor Measurement Data and Beyond	2023	Bob Zhong Bo Gao Jing-ou Liu D. G. O. Mclntyre Wang Cg
+	Suppl Table 2 from A Method to Summarize Toxicity in Cancer Randomized Clinical Trials	2023	Mariana Carbini Mayte Suárez‐Fariñas Robert G. Maki
+	Suppl Table 2 from A Method to Summarize Toxicity in Cancer Randomized Clinical Trials	2023	Mariana Carbini Mayte Suárez‐Fariñas Robert G. Maki
+	Table S1 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework	2023	Ida Netterberg Mats O. Karlsson Leon W.M.M. Terstappen Miriam Koopman Cornelis J.A. Punt Lena E. Friberg
+	Table S1 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework	2023	Ida Netterberg Mats O. Karlsson Leon W.M.M. Terstappen Miriam Koopman Cornelis J.A. Punt Lena E. Friberg
+	Supplementary Methods from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework	2023	Ida Netterberg Mats O. Karlsson Leon W.M.M. Terstappen Miriam Koopman Cornelis J.A. Punt Lena E. Friberg
+	Supplementary Methods from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework	2023	Ida Netterberg Mats O. Karlsson Leon W.M.M. Terstappen Miriam Koopman Cornelis J.A. Punt Lena E. Friberg
+	Assessment of Tumor Growth Inhibition Metrics to Predict Overall Survival	2014	Laurent Claret René Bruno
+	Supplementary Figure S2 from Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker	2023	Alexia Iasonos Paul B. Chapman Jaya M. Satagopan

Works That Cite This (0)

Action	Title	Year	Authors

Works Cited by This (0)

Action	Title	Year	Authors